Protein-profile alterations induced by a model of sporadic Alzheimer’s disease

Alzheimer’s disease (AD), one of the most common forms of dementia, where loss of memory is the first and most characteristic symptom, is emerging as one of the biggest public health burdens in the aging Western society. Although the diagnosis is frequently made with cognitive tests and imaging, the...

Full description

Saved in:
Bibliographic Details
Main Authors: Dimitar Bakalov, Daniela Pechlivanova, Elitsa Stoyanova, Zafer Sabit, Radka Tafradjiiska-Hadjiolova, Lubomir Traikov
Format: Article
Language:English
Published: Pensoft Publishers 2025-08-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/148412/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233353013723136
author Dimitar Bakalov
Daniela Pechlivanova
Elitsa Stoyanova
Zafer Sabit
Radka Tafradjiiska-Hadjiolova
Lubomir Traikov
author_facet Dimitar Bakalov
Daniela Pechlivanova
Elitsa Stoyanova
Zafer Sabit
Radka Tafradjiiska-Hadjiolova
Lubomir Traikov
author_sort Dimitar Bakalov
collection DOAJ
description Alzheimer’s disease (AD), one of the most common forms of dementia, where loss of memory is the first and most characteristic symptom, is emerging as one of the biggest public health burdens in the aging Western society. Although the diagnosis is frequently made with cognitive tests and imaging, the use of biochemical markers in clinical practice is emerging for early diagnosis and prevention. This research aimed to study the effects of the experimental model of AD on the protein profile of the hippocampus and cerebrospinal fluid (CSF). We used an experimental model of sporadic AD induced by intracerebroventricular (ICV) injection of streptozotocin (STZ) in adult male Wistar rats. We performed SDS-PAGE and compared the results to known alterations in the protein profiles of AD patients. This model of AD caused the occurrence of impaired spatial memory and some unexpected protein changes demonstrated by unusual spikes in the densitogram, suggesting posttranslational changes of albumin and other transporter proteins in the hippocampus and CSF. These data suggest that such posttranslational changes may partly contribute to the pathogenesis of AD and can serve as a starting point for further evaluation of the STZ model’s strengths and limitations in studying this disorder.
format Article
id doaj-art-c6de041afa864305ae013341b5e4deca
institution Kabale University
issn 2603-557X
language English
publishDate 2025-08-01
publisher Pensoft Publishers
record_format Article
series Pharmacia
spelling doaj-art-c6de041afa864305ae013341b5e4deca2025-08-20T07:33:03ZengPensoft PublishersPharmacia2603-557X2025-08-01721810.3897/pharmacia.72.e148412148412Protein-profile alterations induced by a model of sporadic Alzheimer’s diseaseDimitar Bakalov0Daniela Pechlivanova1Elitsa Stoyanova2Zafer Sabit3Radka Tafradjiiska-Hadjiolova4Lubomir Traikov5Medical University of SofiaInstitute of Neurobiology, Bulgarian Academy of SciencesMedical University of SofiaMedical University of SofiaMedical University of SofiaMedical University of SofiaAlzheimer’s disease (AD), one of the most common forms of dementia, where loss of memory is the first and most characteristic symptom, is emerging as one of the biggest public health burdens in the aging Western society. Although the diagnosis is frequently made with cognitive tests and imaging, the use of biochemical markers in clinical practice is emerging for early diagnosis and prevention. This research aimed to study the effects of the experimental model of AD on the protein profile of the hippocampus and cerebrospinal fluid (CSF). We used an experimental model of sporadic AD induced by intracerebroventricular (ICV) injection of streptozotocin (STZ) in adult male Wistar rats. We performed SDS-PAGE and compared the results to known alterations in the protein profiles of AD patients. This model of AD caused the occurrence of impaired spatial memory and some unexpected protein changes demonstrated by unusual spikes in the densitogram, suggesting posttranslational changes of albumin and other transporter proteins in the hippocampus and CSF. These data suggest that such posttranslational changes may partly contribute to the pathogenesis of AD and can serve as a starting point for further evaluation of the STZ model’s strengths and limitations in studying this disorder.https://pharmacia.pensoft.net/article/148412/download/pdf/
spellingShingle Dimitar Bakalov
Daniela Pechlivanova
Elitsa Stoyanova
Zafer Sabit
Radka Tafradjiiska-Hadjiolova
Lubomir Traikov
Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
Pharmacia
title Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
title_full Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
title_fullStr Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
title_full_unstemmed Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
title_short Protein-profile alterations induced by a model of sporadic Alzheimer’s disease
title_sort protein profile alterations induced by a model of sporadic alzheimer s disease
url https://pharmacia.pensoft.net/article/148412/download/pdf/
work_keys_str_mv AT dimitarbakalov proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease
AT danielapechlivanova proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease
AT elitsastoyanova proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease
AT zafersabit proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease
AT radkatafradjiiskahadjiolova proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease
AT lubomirtraikov proteinprofilealterationsinducedbyamodelofsporadicalzheimersdisease